Literature DB >> 26916048

The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer-The Problem Is How to Avoid Finding These Cancers.

Giorgio Gandaglia1, Alberto Briganti2, Nicola Fossati2, Andrea Salonia2, Alexandre Mottrie3, James Catto4, Francesco Montorsi5.   

Abstract

One of the most effective ways to reduce overtreatment of prostate cancer is to limit its detection in men with low-risk disease. Although many data are currently missing, we foresee a future with reduced prostate-specific antigen (PSA) testing in men selected through baseline PSA values or genetic predisposition. Then selective biopsy using multiparametric magnetic resonance imaging and longitudinal biomarkers will play a role.
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26916048     DOI： 10.1016/j.eururo.2016.02.032

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  9 in total

1.  Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy.

Authors:  Hakmin Lee; Chan Kyo Kim; Byung Kwan Park; Hyun Hwan Sung; Deok Hyun Han; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Han Yong Choi; Hyun Moo Lee
Journal:  World J Urol       Date:  2016-10-13       Impact factor: 4.226

2.  How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?

Authors:  Yu Zhang; Na Zeng; FengBo Zhang; YangXinRui Huang; Ye Tian
Journal:  Int J Clin Oncol       Date:  2019-08-31       Impact factor: 3.402

3.  PSA Testing Use and Prostate Cancer Diagnostic Stage After the 2012 U.S. Preventive Services Task Force Guideline Changes.

Authors:  Christopher J Magnani; Kevin Li; Tina Seto; Kathryn M McDonald; Douglas W Blayney; James D Brooks; Tina Hernandez-Boussard
Journal:  J Natl Compr Canc Netw       Date:  2019-07-01       Impact factor: 11.908

Review 4.  Grade Migration of Prostate Cancer in the United States During the Last Decade.

Authors:  Leonardo D Borregales; Gina DeMeo; Xiangmei Gu; Emily Cheng; Vanessa Dudley; Edward M Schaeffer; Himanshu Nagar; Sigrid Carlsson; Andrew Vickers; Jim C Hu
Journal:  J Natl Cancer Inst       Date:  2022-07-11       Impact factor: 11.816

5.  A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk.

Authors:  E J Bass; A Pantovic; M Connor; R Gabe; A R Padhani; A Rockall; H Sokhi; H Tam; M Winkler; H U Ahmed
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-11-20       Impact factor: 5.554

6.  Comparison of bi- and multiparametric magnetic resonance imaging to select men for active surveillance.

Authors:  Karen-Cecilie D Thestrup; Vibeke Løgager; Lars Boesen; Henrik S Thomsen
Journal:  Acta Radiol Open       Date:  2019-07-31

7.  Outcome of 5-year follow-up in men with negative findings on initial biparametric MRI.

Authors:  Karen-Cecilie Kortenbach; Lars Boesen; Vibeke Løgager; Henrik S Thomsen
Journal:  Heliyon       Date:  2021-11-06

8.  Early experience in avoiding biopsies for biopsy-naïve men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2: A 2-year follow-up study.

Authors:  Karen-Cecilie Kortenbach; Vibeke Løgager; Henrik S Thomsen; Lars Boesen
Journal:  Acta Radiol Open       Date:  2022-04-20

9.  Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.

Authors:  Lars Boesen; Nis Nørgaard; Vibeke Løgager; Ingegerd Balslev; Rasmus Bisbjerg; Karen-Cecilie Thestrup; Mads D Winther; Henrik Jakobsen; Henrik S Thomsen
Journal:  JAMA Netw Open       Date:  2018-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.